- Home
- WLGS vs BDRX Comparison
WLGS vs BDRX Comparison
Compare WLGS & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- BDRX
- Stock Information
- Founded
- WLGS 1981
- BDRX 2000
- Country
- WLGS Hong Kong
- BDRX United Kingdom
- Employees
- WLGS N/A
- BDRX N/A
- Industry
- WLGS Engineering & Construction
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- WLGS Consumer Discretionary
- BDRX Health Care
- Exchange
- WLGS Nasdaq
- BDRX Nasdaq
- Market Cap
- WLGS 4.4M
- BDRX 5.8M
- IPO Year
- WLGS 2023
- BDRX N/A
- Fundamental
- Price
- WLGS $0.04
- BDRX $0.90
- Analyst Decision
- WLGS
- BDRX
- Analyst Count
- WLGS 0
- BDRX 0
- Target Price
- WLGS N/A
- BDRX N/A
- AVG Volume (30 Days)
- WLGS 40.2M
- BDRX 3.2M
- Earning Date
- WLGS 08-14-2025
- BDRX 04-11-2025
- Dividend Yield
- WLGS N/A
- BDRX N/A
- EPS Growth
- WLGS N/A
- BDRX N/A
- EPS
- WLGS N/A
- BDRX N/A
- Revenue
- WLGS $3,951,649.00
- BDRX N/A
- Revenue This Year
- WLGS N/A
- BDRX N/A
- Revenue Next Year
- WLGS N/A
- BDRX N/A
- P/E Ratio
- WLGS N/A
- BDRX N/A
- Revenue Growth
- WLGS N/A
- BDRX N/A
- 52 Week Low
- WLGS $0.03
- BDRX $0.78
- 52 Week High
- WLGS $9.66
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- WLGS 25.41
- BDRX 39.25
- Support Level
- WLGS $0.05
- BDRX $0.85
- Resistance Level
- WLGS $0.05
- BDRX $0.97
- Average True Range (ATR)
- WLGS 0.02
- BDRX 0.11
- MACD
- WLGS 0.01
- BDRX -0.00
- Stochastic Oscillator
- WLGS 3.27
- BDRX 28.24
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED. WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, water supply and sewage disposal systems, and site project management.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.